Council for Innovation Promotion

Blog: New Op-Ed from Retired Judges Paul Michel and Kathleen O’Malley: Patent Eligibility Restoration Act Would Fuel US Competitiveness, 10/3/2025

In a recent op-ed for Bloomberg Law, C4IP Board Members and retired Federal Circuit Judges Paul Michel and Kathleen O’Malley argue that Congress must pass the bipartisan Patent Eligibility Restoration Act in order to repair the damage the Supreme Court has inflicted on America’s innovation ecosystem. For more than a decade, a series of rulings […]

Blog: New Op-Ed from Retired Judges Paul Michel and Kathleen O’Malley: Patent Eligibility Restoration Act Would Fuel US Competitiveness, 10/3/2025 Read More »

Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA)

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the U.S. patent system by deciding that certain categories of innovation should not receive patents by widening the “judicial exceptions” to what is eligible to be patented under 35 U.S.C. § 101. Starting in

Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA) Read More »

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a crucial role in promoting innovation — both in the drug industry and in other sectors — lawmakers and activists cite these myths as evidence of the need for legislation that would limit or

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry Read More »

C4IP Coalition Updates: August 2025

August Highlights: Setting the Record Straight on the DOJ/FTC Listening Sessions The Department of Justice and Federal Trade Commission recently hosted listening sessions on “Lowering Americans’ Drug Prices Through Competition.” While aimed at exploring ways to expand generic and biosimilar availability, the sessions amplified misleading claims about the patent system — such as allegations of

C4IP Coalition Updates: August 2025 Read More »

New Op-Ed from C4IP Co-Chair Andrei Iancu and former NATO Deputy Secretary General Mircea Geoană: To Defend Nations, NATO Must Defend Innovation

In a new piece for Newsweek, Mircea Geoană, former NATO deputy secretary general and president of the Aspen Institute Romania, and Andrei Iancu, C4IP co-chair and former USPTO Director, warn that protecting intellectual property (IP) is not merely a trade issue, but a national security imperative. Strong and enforceable IP rights give innovators the confidence

New Op-Ed from C4IP Co-Chair Andrei Iancu and former NATO Deputy Secretary General Mircea Geoană: To Defend Nations, NATO Must Defend Innovation Read More »

Op-Ed from Former U.S. Ambassador to China Gary Locke: China Cutting Corners on Technology

In a piece published by Newsweek, C4IP Board Member and former U.S. Ambassador to China Gary Locke explains how, even as Chinese companies debut world-class technologies — like BYD’s lightning-quick EV charger and DeepSeek’s powerful AI model — some Chinese businesses and leaders are undermining the international agreements that underpin global innovation. Locke points to

Op-Ed from Former U.S. Ambassador to China Gary Locke: China Cutting Corners on Technology Read More »

Scroll to Top